Peroxynitrite, the product of nitric oxide and superoxide, causes myocardial injury in the isolated perfused rat heart

被引:46
|
作者
Lopez, BL
Liu, GL
Christopher, TA
Ma, XL
机构
[1] Division of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA
[2] Division of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA 19107
关键词
peroxynitrite; myocardium; ischemia reperfusion;
D O I
10.1097/00019501-199703000-00005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Recent studies have determined that the product of( ).NO and superoxide is peroxynitrite (ONOO-), an anion with deleterious tissue-oxidant effects. Objective To examine the effects of ONOO- on the isolated perfused rat heart, Sprague-Dawley rat hearts were perfused with a cell-free, Krebs-Henseleit solution on a Langendorf perfusion apparatus. The hearts were subjected to 30 min infusions of vehicle (control); 10 mu mol/l S-nitroso-N-acetylpenicillamine (SNAP), an NO donor; 10 mu mol/l pyrogallol, a superoxide generator); 10 mu mol/l SNAP plus 10 mu mol/l pyrogallol, a mixture that generates peroxynitrite; or 10 mu mol/l SNAP plus 10 mu mol/l pyrogallol plus 300 U/ml superoxide dismutase, Results SNAP or pyrogallol alone had no effect on cardiac function at the concentration used; however, infusion of the combination of SNAP and pyrogallol resulted in significant decreases in left ventricular developed pressure (to 83 +/- 4%, P< 0.01, versus vehicle) and dp/dt(max) (to 76 +/- 6.2%, P< 0.01, versus vehicle), and also resulted in a significant increase in production of lactic dehydrogenase (to 118 +/- 4%, P< 0.01, versus vehicle). The administration of superoxide dismutase with SNAP and pyrogallol reversed these deleterious effects, Conclusion These results suggest that the formation of peroxynitrite significantly enhances the toxicities of (NO)-N-. and O-2(.-) and causes marked cardiac injury.
引用
收藏
页码:149 / 153
页数:5
相关论文
共 50 条
  • [1] Peroxynitrite aggravates myocardial reperfusion injury in the isolated perfused rat heart
    Ma, XL
    Lopez, BL
    Liu, GL
    Christopher, TA
    Ischiropoulos, H
    CARDIOVASCULAR RESEARCH, 1997, 36 (02) : 195 - 204
  • [2] Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning
    Ferdinandy, P
    Schulz, R
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (04) : 532 - 543
  • [3] Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats
    Liu, PT
    Hock, CE
    Nagele, R
    Wong, PYK
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 272 (05): : H2327 - H2336
  • [4] Endothelial nitric oxide synthase inhibition in perfused isolated rat heart
    Bettini, M
    Biondi, R
    Cantalupo, T
    Caballero, LC
    Magni, F
    Paolocci, N
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1997, 434 (03): : 2 - 2
  • [5] Quantitation of superoxide, nitric oxide, and peroxynitrite generation in the postischemic heart
    Wang, PH
    Samouilov, A
    Kuppusamy, P
    Zweier, JL
    CIRCULATION, 1996, 94 (08) : 2733 - 2733
  • [7] Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis
    Landino, LM
    Crews, BC
    Timmons, MD
    Morrow, JD
    Marnett, LJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (26) : 15069 - 15074
  • [8] THE CHEMISTRY OF PEROXYNITRITE - A PRODUCT FROM THE REACTION OF NITRIC-OXIDE WITH SUPEROXIDE
    PRYOR, WA
    SQUADRITO, GL
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1995, 268 (05) : L699 - L722
  • [9] Role of nitric oxide, superoxide and peroxynitrite in cytokine-induced myocardial contractile failure in rat hearts
    Ferdinándy, P
    Ambrus, I
    Daniel, H
    Csonka, C
    Rothery, R
    Schulz, R
    JOURNAL OF PHYSIOLOGY-LONDON, 2000, 526 : 83P - 84P
  • [10] PEROXYNITRITE, A PRODUCT OF SUPEROXIDE AND NITRIC-OXIDE, PRODUCES CORONARY VASORELAXATION IN DOGS
    LIU, S
    BECKMAN, JS
    KU, DD
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 268 (03): : 1114 - 1121